These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3754756)

  • 1. Pharmacokinetics of atracurium and its metabolites.
    Ward S; Weatherley BC
    Br J Anaesth; 1986; 58 Suppl 1():6S-10S. PubMed ID: 3754756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of atracurium and other non-depolarizing neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction.
    Miller RD
    Br J Anaesth; 1986; 58 Suppl 1():11S-13S. PubMed ID: 2871850
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism and pharmacokinetics of atracurium].
    Colin JN; Singlas E
    Ann Fr Anesth Reanim; 1985; 4(6):465-70. PubMed ID: 2936284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure).
    Ward S; Neill EA
    Br J Anaesth; 1983 Dec; 55(12):1169-72. PubMed ID: 6689126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.
    Ward S; Boheimer N; Weatherley BC; Simmonds RJ; Dopson TA
    Br J Anaesth; 1987 Jun; 59(6):697-706. PubMed ID: 3606914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function.
    Vandenbrom RH; Wierda JM; Agoston S
    Clin Pharmacokinet; 1990 Sep; 19(3):230-40. PubMed ID: 2394062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic studies in the cat with atracurium: a neuromuscular blocking agent designed for non-enzymic inactivation at physiological pH.
    Neill EA; Chapple DJ
    Xenobiotica; 1982 Mar; 12(3):203-10. PubMed ID: 7113256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renal failure on laudanosine excretion in man.
    Fahey MR; Rupp SM; Canfell C; Fisher DM; Miller RD; Sharma M; Castagnoli K; Hennis PJ
    Br J Anaesth; 1985 Nov; 57(11):1049-51. PubMed ID: 3840380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atracurium and severe hepatic disease: a case report.
    Gyasi HK; Naguib M
    Can Anaesth Soc J; 1985 Mar; 32(2):161-4. PubMed ID: 3838694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atracurium: an overview.
    Hughes R
    Br J Anaesth; 1986; 58 Suppl 1():2S-5S. PubMed ID: 2423104
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism and kinetics of atracurium: an overview.
    Neill EA; Chapple DJ; Thompson CW
    Br J Anaesth; 1983; 55 Suppl 1():23S-25S. PubMed ID: 6688012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of portacaval shunt and/or renal vessel ligation on disposition of muscle relaxants].
    Aoki T
    Masui; 1986 Mar; 35(3):428-39. PubMed ID: 2872346
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose).
    Ward S; Neill EA; Weatherley BC; Corall IM
    Br J Anaesth; 1983 Feb; 55(2):113-8. PubMed ID: 6687550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of atracurium in man v. rat.
    Baraka A
    Br J Anaesth; 1986 Aug; 58(8):940-1. PubMed ID: 3755349
    [No Abstract]   [Full Text] [Related]  

  • 16. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation.
    Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC
    Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.
    Fahey MR; Morris RB; Miller RD; Nguyen TL; Upton RA
    Br J Anaesth; 1981 Oct; 53(10):1049-53. PubMed ID: 6117300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laudanosine, an atracurium and cisatracurium metabolite.
    Fodale V; Santamaria LB
    Eur J Anaesthesiol; 2002 Jul; 19(7):466-73. PubMed ID: 12113608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atracurium-receptor kinetics: simple behavior from a mixture.
    Amaki Y; Waud BE; Waud DR
    Anesth Analg; 1985 Aug; 64(8):777-80. PubMed ID: 3839351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.